Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress
Clinical Collections
Advances in Alzheimer’s

Keynote webinar | Spotlight on medication adherence

LIVE: Thursday 27th June 2024, 18:00-19:30 (CEST)
Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.
ADVANCED SEARCH
Log in
Top
Hepatology International
Published in: Hepatology International 1/2021

01-02-2021 | Liver Transplantation | Letter to the Editor

How can we reduce the impact of COVID-19 pandemic on timely access to liver transplantation in children?

Authors: Mettu Srinivas Reddy, Jagadeesh Menon, Abdul Rahman Hakeem, Shivakumar Murugesan, Gomathy Narasimhan, Naresh Shanmugham, Mohamed Rela

Published in: Hepatology International | Issue 1/2021

Login to get access

Excerpt

The impact of the COVID-19 pandemic on access to pediatric liver transplantation (LT) is likely to be substantial due to a disproportionate reduction in pediatric deceased donors and a disinclination to split liver grafts during a pandemic. Pediatric living donor liver transplantation (LDLT) is an attractive alternative in this setting. However, COVID-19 related concerns, restrictions on people movement and reduced elective clinical activity can disrupt timely access to pediatric liver care and liver transplant. …
Appendix
Available only for authorised users
Metadata
Title
How can we reduce the impact of COVID-19 pandemic on timely access to liver transplantation in children?
Authors
Mettu Srinivas Reddy
Jagadeesh Menon
Abdul Rahman Hakeem
Shivakumar Murugesan
Gomathy Narasimhan
Naresh Shanmugham
Mohamed Rela
Publication date
01-02-2021
Publisher
Springer India
Published in
Hepatology International / Issue 1/2021
Print ISSN: 1936-0533
Electronic ISSN: 1936-0541
DOI
https://doi.org/10.1007/s12072-020-10128-9

Other articles of this Issue 1/2021

Hepatology International 1/2021 Go to the issue

Review Article

Management of primary sclerosing cholangitis and its complications: an algorithmic approach

Original Article

Dipeptidyl peptidase-4 inhibitors may accelerate cirrhosis decompensation in patients with diabetes and liver cirrhosis: a nationwide population-based cohort study in Taiwan

Editorial

Is it time to spit? More evidence for the oral–gut–liver axis in liver disease

Original Article

Transition rates to cirrhosis and liver cancer by age, gender, disease and treatment status in Asian chronic hepatitis B patients

Review Article

How does hepatic lipid accumulation lead to lipotoxicity in non-alcoholic fatty liver disease?

Original Article

Efficacy of peg-interferon–nucleoside analog sequential optimization therapy in HBeAg-positive patients with CHB
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Reserve your place

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

Read more

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Pediatric Cardiology Video

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

Cardiopulmonary Comorbidity Video

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Valvular Heart Disease Video

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

ACC 2024 Congress Coverage

Year in Review: Heart failure and cardiomyopathies

Heart Failure Video

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.

Watch now

Semaglutide benefits people with type 2 diabetes and obesity-related heart failure

16-04-2024 Type 2 Diabetes News

Incentivised to exercise

11-04-2024 Lifestyle Modifications News

New intervention for STEMI-related cardiogenic shock

10-04-2024 Myocardial Infarction News

» View more highlights on the ACC 2024 congress hub page

Image Credits